Stock Taper
OACCW
OAKTREE ACQUISITION CORP. III LIFE SCIENCES
NASDAQ
$0.86
▼ DOWN 4.37% (-0.04)

KEY STATISTICS

Market Cap$241.61 M
52w High$0.99
52w Low$0.86
Dividend Yield
Frequency
P/E
Volume2.83K
Shares Out.24.56M

COMPANY

LEADERSHIP

Zaid Pardesi
CHIEF EXECUTIVE
Zaid Pardesi

ABOUT

SECTOR
Financial Services
WENT PUBLIC
October 6, 2025
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
1,500

PRICE

$0.86 ▼ DOWN 4.37% (−$0.04)
$0.90$1.05$1.2011:21 AM12:04 PM12:48 PM1:31 PM2:14 PM2:58 PM3:41 PM0.86

About Oaktree Acquisition Corp. III Life Sciences

https://www.oaktreeacquisitioncorp.com/oac-iii ↗

Oaktree Acquisition Corp. III Life Sciences presently lacks significant commercial operations. Its primary focus is on completing a business combination, which could take the form of a merger, share exchange, asset acquisition, stock purchase, reorganization, or a similar corporate transaction, with one or more entities. The company aims to identify and acquire businesses operating in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors across North America and Europe. Incorporated in 2024, its base of operations is in Los Angeles, California.

INDUSTRY

Shell Companies

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets4
Debt To Equity1
Price To Earnings4
Price To Book1
Overall Score2

INSIDER TRADES

Martinez George Arthur
· —
2025-10-29
BERRY DAVID A
· —
2025-10-17

SECTORS PEERS

PEERPRICE
PLMKW$0.35COMPARE
GPATW$0.17COMPARE
LPAAW$0.18COMPARE
DRDBW$0.20COMPARE
SIMAW$0.18COMPARE
MACIW$0.12COMPARE